Janet S. Vergis

CIK 1590794 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.53M

Companies

5

Total Filings

78

Lifetime Open-Market Net

-$3.65M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XRAY Director 67,324 $10.09 $679.3K $0 31 2026-06-05
CHDw Director 17,102 -$3.65M 30 2026-05-06
TEVA Director 73,697 $34.63 $2.55M $0 10 2025-06-09
AMRX Director 18,257 $16.20 $295.8K $0 2 2019-05-08
Impax Laboratories, LLC (IPXL) Delisted Director 12,150 $0 3 2017-05-17

Recent Filings · Page 4 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-11-16 XRAY Grant (A) +6,382 $0 EDGAR
2022-08-08 TEVA Grant (A) $0 EDGAR
2022-07-01 CHDw Grant (A) +648 $60.0K EDGAR
2022-06-16 TEVA Exer (M) +14,479 $0 EDGAR
2022-06-14 CHDw Grant (A) $0 EDGAR
2022-04-11 XRAY Grant (A) +7 $0 EDGAR
2022-01-19 XRAY Grant (A) +5 $0 EDGAR
2021-10-12 XRAY Grant (A) +5 $331 EDGAR
2021-07-13 XRAY Grant (A) +5 $331 EDGAR
2021-07-01 CHDw Grant (A) +1,409 $120.1K EDGAR
Showing 3140 of 78
Page 4 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.